发明名称 PROCEDURE FOR ENCAPSULATING NSAIDS
摘要 This disclosure is directed to preparation of individual taste-masked, high bioavailability, high payload, microcapsules by microencapsulation of water-insoluble NSAID drug materials in the substantia l absence of microcapsule agglomerates. These taste-mask ed microcapsules contain a high payload, e.g., about 83+ wt. % of said NSAID) d rug material having high bioavailability and can then be formulated into chewable tablets and liquid aqueous suspensions for medicina l use. Both cellulose acetate phthalate and gelatin are the mivcroencapsulating polymer wall material. Control of pH, controlled additio n of a Hofmeister (lyotropic) salt, microencapsulation o f the water-insoluble NSAID medicament with a liquid phase of both cellulose aceta te phthalate and gelatin microencapsulating material and the subsequent insolubilization of said liquid encapsulating material after it is wrapped around the medicament core with dilute aci d are important process parameters to achieving the proper individual microcapsule s to obtain highly bioavailability task-masked, water-in soluble NSAID drug materials, especially, naproxen and ibuprofen by microencapsulati on alone.
申请公布号 CA2169376(C) 申请公布日期 2003.10.21
申请号 CA19942169376 申请日期 1994.08.09
申请人 EURAND AMERICA, INCORPORATED 发明人 GHANTA, SAMBASIVA RAO;GUISINGER, ROBERT EDMOND
分类号 A61K9/00;A61K9/50;A61K31/192;(IPC1-7):A61K9/50;A61K31/19 主分类号 A61K9/00
代理机构 代理人
主权项
地址